Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP472012.RAEaW8-QnwtN-Ur-FFfLMkASRGYsobiVEwFxLj2PiYvsw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP472012.RAEaW8-QnwtN-Ur-FFfLMkASRGYsobiVEwFxLj2PiYvsw130_assertion type Assertion NP472012.RAEaW8-QnwtN-Ur-FFfLMkASRGYsobiVEwFxLj2PiYvsw130_head.
- NP472012.RAEaW8-QnwtN-Ur-FFfLMkASRGYsobiVEwFxLj2PiYvsw130_assertion wasGeneratedBy ECO_0000203 NP472012.RAEaW8-QnwtN-Ur-FFfLMkASRGYsobiVEwFxLj2PiYvsw130_provenance.
- NP472012.RAEaW8-QnwtN-Ur-FFfLMkASRGYsobiVEwFxLj2PiYvsw130_assertion wasDerivedFrom befree-20150227 NP472012.RAEaW8-QnwtN-Ur-FFfLMkASRGYsobiVEwFxLj2PiYvsw130_provenance.
- NP472012.RAEaW8-QnwtN-Ur-FFfLMkASRGYsobiVEwFxLj2PiYvsw130_assertion SIO_000772 14965242 NP472012.RAEaW8-QnwtN-Ur-FFfLMkASRGYsobiVEwFxLj2PiYvsw130_provenance.
- NP472012.RAEaW8-QnwtN-Ur-FFfLMkASRGYsobiVEwFxLj2PiYvsw130_assertion evidence source_evidence_literature NP472012.RAEaW8-QnwtN-Ur-FFfLMkASRGYsobiVEwFxLj2PiYvsw130_provenance.
- NP472012.RAEaW8-QnwtN-Ur-FFfLMkASRGYsobiVEwFxLj2PiYvsw130_assertion description "[Clinical efficacy was first established in chemotherapy-induced emesis (and then in radiotherapy-induced and post-operative emesis), where 5-HT(3)-receptor antagonists set a new standard of antiemetic efficacy and tolerability.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP472012.RAEaW8-QnwtN-Ur-FFfLMkASRGYsobiVEwFxLj2PiYvsw130_provenance.